Schroder Investment Management Group Buys 317,284 Shares of UnitedHealth Group Incorporated $UNH

Schroder Investment Management Group grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 35.3% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 1,215,507 shares of the healthcare conglomerate’s stock after acquiring an additional 317,284 shares during the quarter. Schroder Investment Management Group’s holdings in UnitedHealth Group were worth $419,715,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Brighton Jones LLC raised its position in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC boosted its stake in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after buying an additional 2,324 shares in the last quarter. CMT Capital Markets Trading GmbH acquired a new position in UnitedHealth Group during the second quarter worth about $340,000. Vestmark Advisory Solutions Inc. boosted its stake in shares of UnitedHealth Group by 16.0% in the 2nd quarter. Vestmark Advisory Solutions Inc. now owns 14,103 shares of the healthcare conglomerate’s stock valued at $4,400,000 after purchasing an additional 1,942 shares in the last quarter. Finally, Penserra Capital Management LLC increased its position in UnitedHealth Group by 24.8% during the 2nd quarter. Penserra Capital Management LLC now owns 9,586 shares of the healthcare conglomerate’s stock worth $2,990,000 after purchasing an additional 1,902 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on UNH shares. Truist Financial decreased their target price on shares of UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday, February 2nd. UBS Group lowered their target price on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating for the company in a report on Wednesday, January 28th. Leerink Partners reduced their price target on UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating on the stock in a report on Wednesday, January 28th. Evercore upgraded shares of UnitedHealth Group to a “strong-buy” rating in a research report on Tuesday, January 6th. Finally, Barclays decreased their price target on shares of UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating for the company in a research report on Friday, January 30th. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $372.13.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $286.86 on Monday. The stock’s 50 day moving average price is $308.28 and its two-hundred day moving average price is $326.02. The stock has a market capitalization of $260.38 billion, a price-to-earnings ratio of 21.75, a PEG ratio of 1.32 and a beta of 0.41. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.79 and a current ratio of 0.79. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $606.36.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business had revenue of $113.73 billion during the quarter, compared to analyst estimates of $113.38 billion. During the same period in the previous year, the company posted $6.81 EPS. The firm’s revenue was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, March 9th. This represents a $8.84 annualized dividend and a yield of 3.1%. UnitedHealth Group’s dividend payout ratio is presently 67.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.